Analysis of sex differences in cancer-specific survival and perioperative mortality following radical cystectomy: results of a large German multicenter study of nearly 2500 patients with urothelial carcinoma of the bladder.

[1]  C. Stief,et al.  Gender-specific differences in cancer-specific survival after radical cystectomy for patients with urothelial carcinoma of the urinary bladder in pathologic tumor stage T4a. , 2013, Urologic oncology.

[2]  L. Kiemeney,et al.  Epidemiology and risk factors of urothelial bladder cancer. , 2013, European urology.

[3]  C. Stief,et al.  Gender-dependent cancer-specific survival following radical cystectomy , 2012, World Journal of Urology.

[4]  R. Sylvester,et al.  Female gender and carcinoma in situ in the prostatic urethra are prognostic factors for recurrence, progression, and disease-specific mortality in T1G3 bladder cancer patients treated with bacillus Calmette-Guérin. , 2012, European urology.

[5]  E. Messing,et al.  The burden of bladder cancer in men and women: analysis of the years of life lost , 2012, BJU international.

[6]  S. Shariat,et al.  Impact of gender on bladder cancer incidence, staging, and prognosis , 2011, World Journal of Urology.

[7]  P. Carroll,et al.  Transitional cell carcinoma of the bladder: racial and gender disparities in survival (1993 to 2002), stage and grade (1993 to 2007). , 2011, The Journal of urology.

[8]  C. Stief,et al.  Association Between the Number of Dissected Lymph Nodes During Pelvic Lymphadenectomy and Cancer-Specific Survival in Patients with Lymph Node–Negative Urothelial Carcinoma of the Bladder Undergoing Radical Cystectomy , 2011, Annals of Surgical Oncology.

[9]  Samay Jain,et al.  Comparison of 2004 and 1973 World Health Organization grading systems and their relationship to pathologic staging for predicting long-term prognosis in patients with urothelial carcinoma. , 2010, Urology.

[10]  Y. Lotan,et al.  Characteristics and outcomes of patients with clinical carcinoma in situ only treated with radical cystectomy: an international study of 243 patients. , 2010, The Journal of urology.

[11]  B. Bochner,et al.  The effect of age and gender on bladder cancer: a critical review of the literature , 2010, BJU international.

[12]  Arnulf Stenzl,et al.  Gender-specific differences in bladder cancer: a retrospective analysis. , 2008, Gender medicine.

[13]  Cheryl T. Lee,et al.  Patterns of hematuria referral to urologists: does a gender disparity exist? , 2008, Urology.

[14]  A. López-Beltran.  Bladder cancer: Clinical and pathological profile , 2008, Scandinavian journal of urology and nephrology. Supplementum.

[15]  E. Messing,et al.  Promotion of bladder cancer development and progression by androgen receptor signals. , 2007, Journal of the National Cancer Institute.

[16]  K. Naber.  Urogenital infections: The pivotal role of the urologist. , 2006, European urology.

[17]  L. Kiemeney,et al.  Gender differences in stage-adjusted bladder cancer survival. , 2000, Urology.

[18]  P. Muti,et al.  The prognostic role of gender in survival of adult cancer patients. EUROCARE Working Group. , 1998, European journal of cancer.

[19]  J. Witjes,et al.  [Treatment of muscle-invasive and metastatic bladder cancer: update of the EAU guidelines]. , 2012, Actas urologicas espanolas.

[20]  M. Babjuk,et al.  [EAU guidelines on non-muscle-invasive urothelial carcinoma of the bladder, the 2011 update]. , 2012, Actas urologicas espanolas.

[21]  Y. Lotan,et al.  Characteristics and outcomes of patients with pT4 urothelial carcinoma at radical cystectomy: a retrospective international study of 583 patients. , 2010, The Journal of urology.

[22]  E. Messing,et al.  Sex and racial differences in bladder cancer presentation and mortality in the US , 2009, Cancer.

[23]  Hessel Wijkstra,et al.  Ultrasound measurement of detrusor wall thickness in healthy adults , 2006, Neurourology and urodynamics.